# OnCo record paper-hrc-test-oct4a-stem-cell-rev-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hrc-test-oct4a-stem-cell-rev-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hrc-test-oct4a-stem-cell-rev-2021" ;
  schema:name "Quest for Pan-Cancer Diagnosis/Prognosis Ends with HrC Test Measuring Oct4A in Peripheral Blood"@en ;
  schema:description "Epigeneres, a Mumbai company, describes a blood test that scores the activity of an embryonic gene, OCT-4A, and claims it detects and stages any cancer; the paper is a description with case studies, not a validation study with accuracy figures."@en ;
  schema:url <https://onco.cc/key-papers/paper-hrc-test-oct4a-stem-cell-rev-2021/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s12015-021-10167-1>, <https://pubmed.ncbi.nlm.nih.gov/33954878/> ;
  schema:sameAs <https://doi.org/10.1007/s12015-021-10167-1> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Tripathi V, Bhartiya D, Vaid A, Chhabria S, et al." ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/mced/> ;
  onco:drugs <https://onco.cc/drugs/hrc-test/> ;
  onco:companies <https://onco.cc/companies/epigeneres/> .